Filtros de búsqueda

Lista de obras de

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.

artículo científico publicado en 2018

Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS.

artículo científico publicado en 2013

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

artículo científico publicado en 2018

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.

artículo científico publicado en 2018

Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential

scientific article published on 26 August 2019

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension

artículo científico publicado en 2016

In silico approaches for unveiling novel glycobiomarkers in cancer

artículo científico

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

artículo científico publicado en 2015

Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells

scientific article published on 02 April 2020

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

artículo científico publicado en 2017

Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.

artículo científico publicado en 2016

Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies

artículo científico publicado en 2016

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases

artículo científico publicado en 2017

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda